Sanofi - Significant Ownership

Signature - Title
/s/ Alexandra Roger - Alexandra Roger, Head of Legal Corporate and Finance
Location
Paris, France
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sanofi.

Notify me when Sanofi files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Sanofi

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Innate Pharma SA Ordinary Shares, Euro 0.05 nominal value per share 9.05% 8.35M SANOFI Apr 23, 2025

Schedules 13D/G Reported by Sanofi:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.